The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
Open accessAbstract
Epithelial‐to‐mesenchymal transition (EMT) is implicated in a wide array of malignant behaviors of cancers, including proliferation, invasion, and metastasis. Most notably, previou studies have indicated that both cancer stem‐like properties and drug resistance were associated with EMT. Furthermore, microRNAs (miRNAs) play a pivotal role in the regulation of EMT phenotype, as a result, some miRNAs impact cancer stemness and drug resistance. Therefore, understanding the relationship between EMT‐associated miRNAs and cancer stemness/drug resistance is beneficial to both basic research and clinical treatment. In this review, we preliminarily looked into the various roles that the EMT‐associated miRNAs play in the stem‐like nature of malignant cells. Then, we reviewed the interaction between EMT‐associated miRNAs and the drug‐resistant complex signaling pathways of multiple cancers including lung cancer, gastric cancer, gynecologic cancer, breast cancer, liver cancer, colorectal cancer, pancreatic cancer, esophageal cancer, and nasopharyngeal cancer. We finally discussed the relationship between EMT, cancer stemness, and drug resistance, as well as looked forward to the potential applications of miRNA therapy for malignant tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Kong, W., He, L., Coppola, M., Guo, J., Esposito, N. N., Coppola, D., & Cheng, J. Q. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101055 · Cited by 377
RetractedLiu, T., Zhang, X., Du, L., Wang, Y., Liu, X., Tian, H., Wang, L., Li, P., Zhao, Y., Duan, W., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0981-7 · Cited by 264
RetractedFu, X., Liu, M., Qu, S., Ma, J., Zhang, Y., Shi, T., Wen, H., Yang, Y., Wang, S., Wang, J., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0677-7 · Cited by 217
RetractedLin, X., Wang, S., Sun, M., Zhang, C., Wei, C., Yang, C., Dou, R., Liu, Q., & Xiong, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0708-7 · Cited by 207
RetractedSong, J., & Li, Y. (2016) · Cancer Science · doi:10.1111/cas.13104 · Cited by 83
RetractedGuo, J., Jin, D., Wu, Y., Yang, L., Du, J., Gong, K., Chen, W., Dai, J., Miao, S., & Xi, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.001 · Cited by 64
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs
Villarroya-Beltri, C., Gutiérrez-Vázquez, C., Sánchez-Cabo, F., Pérez-Hernández, D., Vázquez, J., Martin-Cofreces, N., Martinez-Herrera, D. J., Pascual-Montano, A., Mittelbrunn, M., & Sánchez-Madrid, F. (2013) · Nature Communications · doi:10.1038/ncomms3980 · Cited by 1,971
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
Vimentin in cancer and its potential as a molecular target for cancer therapy
Satelli, A., & Li, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0735-1 · Cited by 1,557
Epithelial Mesenchymal Transition in Tumor Metastasis
Mittal, V. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043854 · Cited by 1,528
Identification of the tumour transition states occurring during EMT
Pastushenko, I., Brisebarre, A., Sifrim, A., Fioramonti, M., Revenco, T., Boumahdi, S., Van Keymeulen, A., Brown, D., Moers, V., Lemaire, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0040-3 · Cited by 1,495
Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315
MicroRNA control of signal transduction
Inui, M., Martello, G., & Piccolo, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2868 · Cited by 1,272
The biology and role of CD44 in cancer progression: Therapeutic implications
Chen, C., Zhao, S., Karnad, A., & Freeman, J. W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0605-5 · Cited by 1,245
IL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846
Serrano-Gomez, S. J., Maziveyi, M., & Alahari, S. K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0502-x · Cited by 814
Kong, W., Yang, H., He, L., Zhao, J.-J., Coppola, D., Dalton, W. S., & Cheng, J. Q. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00941-08 · Cited by 689
Thomson, S., Buck, E., Petti, F., Griffin, G., Brown, E., Ramnarine, N., Iwata, K. K., Gibson, N., & Haley, J. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1058 · Cited by 663
Tsai, H.-C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F. V., Shin, J. J., Harbom, K. M., Beaty, R., Pappou, E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.029 · Cited by 650
Cancer stem cells (CSCs) in cancer progression and therapy
Najafi, M., Farhood, B., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27740 · Cited by 573
Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M., Wyatt, L., Farshid, G., Lim, Y.-Y., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0103 · Cited by 552
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells
Kröger, C., Afeyan, A., Mraz, J., Eaton, E. N., Reinhardt, F., Khodor, Y. L., Thiru, P., Bierie, B., Ye, X., Burge, C. B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812876116 · Cited by 499
Yauch, R. L., Januario, T., Eberhard, D. A., Cavet, G., Zhu, W., Fu, L., Pham, T. Q., Soriano, R., Stinson, J., Seshagiri, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1492 · Cited by 495
Epithelial–mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck, M., & Christofori, G. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.06.002 · Cited by 475
Lu, J., Ye, X., Fan, F., Xia, L., Bhattacharya, R., Bellister, S., Tozzi, F., Sceusi, E., Zhou, Y., Tachibana, I., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.021 · Cited by 447
Weng, Y.-S., Tseng, H.-Y., Chen, Y.-A., Shen, P.-C., Al Haq, A. T., Chen, L.-M., Tung, Y.-C., & Hsu, H.-L. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0988-0 · Cited by 444
Saxena, M., Stephens, M. A., Pathak, H., & Rangarajan, A. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.61 · Cited by 408
Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools
Li, S.-P., Lin, Z.-X., Jiang, X.-Y., & Yu, X.-Y. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.178 · Cited by 390
Role of microRNAs in drug-resistant ovarian cancer cells
Sorrentino, A., Liu, C.-G., Addario, A., Peschle, C., Scambia, G., & Ferlini, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.017 · Cited by 354
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis
Cai, J., Guan, H., Fang, L., Yang, Y., Zhu, X., Yuan, J., Wu, J., & Li, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65871 · Cited by 331
Exosome-mediated breast cancer chemoresistance via miR-155 transfer
Santos, J. C., Lima, N. D. S., Sarian, L. O., Matheu, A., Ribeiro, M. L., & Derchain, S. F. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-19339-5 · Cited by 325
Mallini, P., Lennard, T., Kirby, J., & Meeson, A. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.09.008 · Cited by 240
Liao, T., & Yang, M. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12096 · Cited by 239
Meidhof, S., Brabletz, S., Lehmann, W., Preca, B., Mock, K., Ruh, M., Schüler, J., Berthold, M., Weber, A., Burk, U., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404396 · Cited by 229
Rho, J. K., Choi, Y. J., Lee, J. K., Ryoo, B.-Y., Na, I. I., Yang, S. H., Kim, C. H., & Lee, J. C. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.05.017 · Cited by 220
Self-citationmiR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
Acunzo, M., Visone, R., Romano, G., Veronese, A., Lovat, F., Palmieri, D., Bottoni, A., Garofalo, M., Gasparini, P., Condorelli, G., et al. (2012) · Oncogene · doi:10.1038/onc.2011.260 · Cited by 192
Wang, X., Zhang, H., Bai, M., Ning, T., Ge, S., Deng, T., Liu, R., Zhang, L., Ying, G., & Ba, Y. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.01.001 · Cited by 192
Kitamura, K., Seike, M., Okano, T., Matsuda, K., Miyanaga, A., Mizutani, H., Noro, R., Minegishi, Y., Kubota, K., & Gemma, A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0448 · Cited by 187
The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction
Li, S., Yi, M., Dong, B., Tan, X., Luo, S., & Wu, K. (2021) · International Journal of Cancer · doi:10.1002/ijc.33386 · Cited by 180
Bai, W., Ye, X., Zhang, M., Zhu, H., Xi, W., Huang, X., Zhao, J., Gu, B., Zheng, G., Yang, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28782 · Cited by 178
Coupling the modules of EMT and stemness: A tunable ‘stemness window’ model
Jolly, M. K., Jia, D., Boareto, M., Mani, S. A., Pienta, K. J., Ben-Jacob, E., & Levine, H. (2015) · Oncotarget · doi:10.18632/oncotarget.4629 · Cited by 171
Du, R., Sun, W., Xia, L., Zhao, A., Yu, Y., Zhao, L., Wang, H., Huang, C., & Sun, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030771 · Cited by 169
Liu, B., Wu, S., Ma, J., Yan, S., Xiao, Z., Wan, L., Zhang, F., Shang, M., & Mao, A. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.09.026 · Cited by 165
Johansson, J., Berg, T., Kurzejamska, E., Pang, M.-F., Tabor, V., Jansson, M., Roswall, P., Pietras, K., Sund, M., Religa, P., et al. (2013) · Oncogene · doi:10.1038/onc.2013.322 · Cited by 157
Zhou, J., Zeng, Q., Wang, H., Zhang, B., Li, S., Nan, X., Cao, N., Fu, C., Yan, X., Jia, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27887 · Cited by 156
MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4
Li, J., Guo, Y., Liang, X.-D., Sun, M., Wang, G., De, W., & Wen-xi, W. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1154-x · Cited by 152
Shi, Z.-M., Wang, L., Shen, H., Jiang, C.-F., Ge, X. Q., Li, D., Wen, Y.-Y., Sun, H.-R., Pan, M.-H., Li, W., et al. (2017) · Oncogene · doi:10.1038/onc.2016.414 · Cited by 148
Ma, X.-L., Hu, B., Tang, W.-G., Xie, S.-H., Ren, N., Guo, L., & Lu, R.-Q. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-0845-z · Cited by 147
miR-145 Antagonizes SNAI1-Mediated Stemness and Radiation Resistance in Colorectal Cancer
Zhu, Y., Wang, C., Becker, S. A., Hurst, K. E., Nogueira, L. M., Findlay, V. J., & Camp, E. R. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.023 · Cited by 139
Gan, L., Xu, M., Hua, R., Tan, C., Zhang, J., Gong, Y., Wu, Z., Weng, W., Sheng, W., & Guo, W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0547-3 · Cited by 130
Võsa, U., Vooder, T., Kolde, R., Fischer, K., Välk, K., Tõnisson, N., Roosipuu, R., Vilo, J., Metspalu, A., & Annilo, T. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20902 · Cited by 127
Izumchenko, E., Chang, X., Michailidi, C., Kagohara, L. T., Ravi, R. K., Paz, K., Brait, M., Hoque, M. O., Ling, S., Bedi, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0110 · Cited by 124
Yu, X., Shi, W., Zhang, Y., Wang, X., Sun, S., Song, Z., Liu, M., Zeng, Q., Cui, S., & Qu, X. (2017) · Scientific Reports · doi:10.1038/srep42226 · Cited by 124
Wang, M., Qiu, R., Yu, S., Xu, X., Li, G., Gu, R., Tan, C., Zhu, W., & Shen, B. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4601 · Cited by 124
Dong, P., Xiong, Y., Watari, H., Hanley, S. J. B., Konno, Y., Ihira, K., Yamada, T., 工藤, 正., Yue, J., & Sakuragi, N. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0415-y · Cited by 123
miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia
Jiang, X., Huang, H., Li, Z.-J., He, C., Li, Y.-Y., Chen, P., Gurbuxani, S., Arnovitz, S., Hong, G.-M., Price, C., et al. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1217519109 · Cited by 122
Li, Q., Liang, X., Wang, Y., Meng, X., Xu, Y., Cai, S., Wang, Z., Liu, J., & Cai, G. (2016) · Scientific Reports · doi:10.1038/srep27157 · Cited by 121
MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1
Zhang, Y., Zheng, L., Huang, J., Gao, F., Lin, X., He, L., Li, D., Li, Z., Ding, Y., & Chen, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093917 · Cited by 119
MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis
Chao, C.-H., Chang, C.-C., Wu, M., Ko, H.-W., Wang, D., Hung, M., Yang, J.-Y., & Chang, C.-J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73351 · Cited by 119
VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug
Kim, M., Jang, K., Miller, P., Picon‐Ruiz, M., Yeasky, T. M., El‐Ashry, D., & Slingerland, J. M. (2017) · Oncogene · doi:10.1038/onc.2017.4 · Cited by 117
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance
Park, K.-S., Raffeld, M. A., Moon, Y. W., Xi, L., Bianco, C., Pham, T. C., Lee, L. C., Mitsudomi, T., Yatabe, Y., Okamoto, I., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73048 · Cited by 115
Papadaki, M. A., Kallergi, G., Zafeiriou, Z., Manouras, L., Theodoropoulos, P. A., Mavroudis, D., Georgoulias, V., & Agelaki, S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-651 · Cited by 113
Bahena, I., Espinosa, M., Ceballos‐Cancino, G., Lizárraga, F., Campos‐Arroyo, D., Schwarz, A., Maldonado, V., & Meléndez-Zajgla, J. (2016) · EMBO Reports · doi:10.15252/embr.201540678 · Cited by 106
MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming
Liu, Y., Lu, L., Wen, D., Liu, D., Dong, L., Gao, D., Bian, X., Zhou, J., Fan, J., & Wu, W. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0841-3 · Cited by 106
Self-citationZhen, Y., Fang, W., Zhao, M., Luo, R., Liu, Y., Fu, Q., Chen, Y., Cheng, C., Zhang, Y., & Liu, Z. (2016) · Oncogene · doi:10.1038/onc.2016.201 · Cited by 105
Self-citationTang, T., Yang, Z., Zhu, Q., Wu, Y., Sun, K., Alahdal, M., Zhang, Y., Xing, Y., Shen, Y., Xia, T., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201801013r · Cited by 105
Role of miRNAs in human cancer metastasis: Implications for therapeutic intervention
Jafri, M., Al-Qahtani, M. H., & Shay, J. W. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.004 · Cited by 104
Yue, J., Lv, D., Wang, C., Li, L., Zhao, Q., Chen, H., & Xu, L. (2018) · Oncogene · doi:10.1038/s41388-018-0276-2 · Cited by 104
Lisse, T. S., & Hewison, M. (2011) · Cell Cycle · doi:10.4161/cc.10.12.15620 · Cited by 102
Brozović, A., Durán, G. E., Wang, Y. C., Francisco, E. B., & Sikic, B. I. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.015 · Cited by 101
Fu, Q., Song, X., Liu, Z., Deng, X., Luo, R., Ge, C., Li, R., Li, Z., Zhao, M., Chen, Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2813 · Cited by 99
miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer
Feliciano, A., Garcia‐Mayea, Y., Jubierre, L., Mir, C., Hummel, M., Castellví, J., Hernández‐Losa, J., Paciucci, R., Sansano, I., Sun, Y., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.544 · Cited by 99
Dasgupta, P., Kulkarni, P., Majid, S., Shahryari, V., Hashimoto, Y., Bhat, N. S., Shiina, M., Deng, G., Saini, S., Tabatabai, Z. L., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0925 · Cited by 97
Xu, Y.-F., Sengupta, T., Kukreja, L., & Minella, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152306 · Cited by 95
Antithetical NFATc1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity
Singh, S. K., Chen, N., Heßmann, E., Siveke, J. T., Lahmann, M., Singh, G., Völker, N., Vogt, S., Esposito, I., Schmidt, A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201489574 · Cited by 95
Chaudhary, A., Mondal, G., Kumar, V., Kattel, K., & Mahato, R. I. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.007 · Cited by 95
NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer
Li, L., Wu, P., Wang, Z., Meng, X., Zha, C., Li, Z., Qi, T., Zhang, Y., Han, B. R., Li, S., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00849-7 · Cited by 95
Lin, X., Zuo, S., Luo, R., Li, Y., Yu, G., Zou, Y., Zhou, Y., Liu, Z., Liu, Y., Hu, Y., et al. (2019) · Theranostics · doi:10.7150/thno.37717 · Cited by 94
Self-citationJu, S.-Y., Chiou, S., & Su, Y. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.09.011 · Cited by 92
Zhou, Y., Hu, Y., Yang, M., Jat, P., Li, K., Lombardo, Y., Xiong, D., Coombes, R. C., Raguz, S., & Yagüe, E. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.167 · Cited by 91
Liu, Y., Li, Y., Wang, R., Qin, S., Liu, J., Su, F., Yang, Y. F., Zhao, F., Wang, Z., & Wu, Q. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0296-0 · Cited by 91
Self-citationZhou, X., Men, X., Zhao, R., Han, J., Fan, Z., Wang, Y., Lv, Y., Zuo, J., Zhao, L., Sang, M., et al. (2018) · Cancer Gene Therapy · doi:10.1038/s41417-017-0005-y · Cited by 89
Wei, H., Liang, F., Cheng, W., Zhou, R., Wu, X., Feng, Y., & Wang, Y. (2017) · Environmental Toxicology · doi:10.1002/tox.22437 · Cited by 87
Zhao, Z., Zhang, L., Yao, Q., & Tao, Z. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2014.73 · Cited by 86
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
Gong, L., Yan, Q., Zhang, Y., Fang, X., Liu, B., & Guan, X. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0393-5 · Cited by 85
miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression
Wang, Y., Zhao, Y., Herbst, A., Kalinski, T., Qin, J., Wang, X., Jiang, Z., Benedix, F., Franke, S., Wartman, T., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001928 · Cited by 84
A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells
Han, X., Zhen, S., Ye, Z., Lu, J., Wang, L., Li, P., Li, J., Zheng, X., Li, H., Chen, W., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000460618 · Cited by 84
Dai, Y., Xie, C., Neis, J. P., Fan, C., Vural, E. A., & Spring, P. M. (2010) · Head & Neck · doi:10.1002/hed.21540 · Cited by 82
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
Nishijima, N., Seike, M., Soeno, C., Chiba, M., Miyanaga, A., Noro, R., Sugano, T., Matsumoto, M., Kubota, K., & Gemma, A. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3331 · Cited by 82
Xiong, Y., Sun, F., Dong, P., Watari, H., Yue, J., Yu, M.-F., Lan, C., Wang, Y., & Ma, Z.-B. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0520-6 · Cited by 81
Chen, D., Huang, J., Zhang, K., Pan, B., Chen, J., De, W., Wang, R., & Chen, L. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.09.008 · Cited by 80
miR-612 suppresses the stemness of liver cancer via Wnt/β-catenin signaling
Tang, J., Tao, Z., Wen, D., Wan, J.-L., Liu, D., Zhang, S., Cui, J., Sun, H., Wang, L., Zhou, J., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.135 · Cited by 80
Qi, Y., Su, L., Chen, D., Zheng, W., & Liu, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000482025 · Cited by 79
Self-citationmiR-374a-5p: A New Target for Diagnosis and Drug Resistance Therapy in Gastric Cancer
Ji, R., Zhang, X., Gu, H., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.07.025 · Cited by 79
miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop
Shi, L., Wang, Y., Lü, Z., Zhang, H., Zhuang, N., Wang, B., Song, Z., Chen, G., Huang, C., Xu, D., et al. (2016) · Oncogene · doi:10.1038/onc.2016.332 · Cited by 71
Lee, J., Guan, W., Han, S., Hong, D., Kim, L.-S., & Kim, H. (2018) · Cancer Science · doi:10.1111/cas.13588 · Cited by 71
Ren, W., Li, D., Chen, X., Li, X., He, Y., Guo, L., Liu, L., Sun, L., & Zhang, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0592-z · Cited by 71
Liu, Q., Guan, Y., Li, Z., Wang, Y., Liu, Y., Cui, R., & Wang, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1370-1 · Cited by 70
Self-citationBocci, F., Jolly, M. K., George, J. T., Levine, H., & Onuchic, J. N. (2018) · Oncotarget · doi:10.18632/oncotarget.25692 · Cited by 68
Lo, P., Zhang, Y., Yao, Y., Wolfson, B., Yu, J. E., Han, S., Duru, N., & Zhou, Q. Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775080 · Cited by 67
SNAI2 Modulates Colorectal Cancer 5-Fluorouracil Sensitivity through miR145 Repression
Findlay, V. J., Wang, C., Nogueira, L. M., Hurst, K. E., Quirk, D. M., Ethier, S. P., O'Carroll, K. F. S., Watson, D. K., & Camp, E. R. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0207 · Cited by 65
MicroRNA-495 induces breast cancer cell migration by targeting JAM-A
Cao, M., Nie, W., Li, J., Zhang, Y., Yan, X., Guan, X., Chen, X., Zen, K., Zhang, C., Jiang, X., et al. (2014) · Protein & Cell · doi:10.1007/s13238-014-0088-2 · Cited by 65
microRNA-125a-3p reduces cells proliferation and migration by targeting Fyn
Ninio-Many, L., Grossman, H., Shomron, N., Chuderland, D., & Shalgi, R. (2013) · Journal of Cell Science · doi:10.1242/jcs.123414 · Cited by 64
Feng, C., Zhang, L., Sun, Y., Li, X., Zhan, L., Lou, Y. J., Wang, Y., Liu, L., & Zhang, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.028 · Cited by 64
Exosomes in Head and Neck Squamous Cell Carcinoma
Cheng, X., Song, F., Zheng, Y., Lv, J., Wang, Q. F., & Xu, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00894 · Cited by 64
Lin, X.-J., He, C., Sun, T., Duan, X.-J., Sun, Y., & Xiong, S. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2992 · Cited by 63
Aptamer-Based Therapeutic Approaches to Target Cancer Stem Cells
Zhou, G., Latchoumanin, O., Bagdesar, M., Hebbard, L., Duan, W., Liddle, C., George, J., & Qiao, L. (2017) · Theranostics · doi:10.7150/thno.20725 · Cited by 63
Zhu, Q., Zhong, A.-L., Hu, H., Zhao, J.-J., Weng, D., Tang, Y., Pan, Q., Zhou, Z.-Q., Song, M., Yang, J.-Y., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0840-4 · Cited by 63
Self-citationLi, L., Pan, D., Chen, Q., Zhang, S.-W., Xie, D., Zheng, X., & Chen, H. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490871 · Cited by 62
Sato, H., Shien, K., Tomida, S., Okayasu, K., Suzawa, K., Hashida, S., Torigoe, H., Watanabe, M., Yamamoto, H., Soh, J., et al. (2017) · Scientific Reports · doi:10.1038/srep40847 · Cited by 61
Hiramoto, H., Muramatsu, T., Ichikawa, D., Tanimoto, K., Yasukawa, S., Otsuji, E., & Inazawa, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04191-w · Cited by 60
Liu, M., Zhou, K., & Cao, Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-245 · Cited by 57
Wang, M., Zhang, R., Zhang, S., Xu, R., & Yang, Q. (2019) · Gene · doi:10.1016/j.gene.2019.03.043 · Cited by 55
Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells
Robertis, M. D., Poeta, M. L., Signori, E., & Fazio, V. M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.008 · Cited by 54
Wang, T., Wang, D., Zhang, L., Yang, P. C., Wang, J., Liu, Q., Yan, F., & Lin, F. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1195-y · Cited by 53
Deng, X., Liu, Z., Liu, X., Fu, Q., Deng, T., Lü, J., Liu, Y., Liang, Z., Jiang, Q., Cheng, C., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.01.023 · Cited by 52
Self-citationMiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R
Zhang, Y., Huang, S., Guo, Y., & Li, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.059 · Cited by 51
Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes
Li, X. O., Xu, F., Chang, C., Byon, J. C. H., Papayannopoulou, T., Deeg, H. J., & Marcondes, A. M. (2012) · Haematologica · doi:10.3324/haematol.2012.071753 · Cited by 50
Zhang, P., Lu, X., Shi, Z., Li, X., Zhang, Y., Zhao, S., & Liu, H. (2019) · Gene · doi:10.1016/j.gene.2019.05.058 · Cited by 50
The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis
Ren, L., Yan, T., Shen, C., Tang, J., Kong, X., Wang, Y., Chen, J., Liu, Q., He, J., Zhong, M., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0732-5 · Cited by 49
ZNF281/ZBP-99: a new player in epithelial–mesenchymal transition, stemness, and cancer
Hahn, S., & Hermeking, H. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1160-3 · Cited by 48
Durán, G. E., Wang, Y. C., Moisan, F., Francisco, E. B., & Sikic, B. I. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.102 · Cited by 48
Li, J., Hao, Y., Mao, W., Xue, X., Xu, P., Liu, L., Yuan, J., Zhang, D., Li, N., Chen, H., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0707-8 · Cited by 47
Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus
Yeh, T., Wang, F., Chen, T., Yeh, C., Yu, M., Jan, Y.-Y., & Chen, M. (2013) · Annals of Surgery · doi:10.1097/sla.0000000000000223 · Cited by 46
Zhao, Y., Han, M., Xiong, Y., Wang, L., Fei, Y., Shen, X., Zhu, Y., & Liang, Z. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.164 · Cited by 46
Qiu, L., Zhang, G., Yu, L., Wang, H., Jia, X., & Wang, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-30978-6 · Cited by 46
Cao, L., Wan, Q., Li, F., & Tang, C. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.9.104 · Cited by 46
Zhao, Y., Ma, K., Yang, S., Zhang, X., Wang, F., Zhang, X., Liu, H., & Fan, Q. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4409 · Cited by 45
Self-citationHan, S., Shi, Y., Sun, L., Liu, Z., Song, T., & Liu, Q. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.38000 · Cited by 45
Ma, J., Zeng, F., Ma, C., Pang, H., Fang, B., Lian, C., Yin, B., Zhang, X., Wang, Z., & Xia, J. (2016) · PubMed Central · Cited by 44
Yang, R., Zhan, M., Xu, S., Long, M., Yang, L., Chen, W., Huang, S., Liu, Q., Zhou, J., Zhu, J., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.530 · Cited by 44
Ho, K., Cheng, C., Chou, C., Chen, P., Liu, A.-J., Lin, C., Shih, C.-M., & Chen, K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104390 · Cited by 44
Su, C., Cheng, X., Li, Y., Han, Y., Song, X., Yu, D., Cao, X., & Liu, Z. (2018) · Cancer Medicine · doi:10.1002/cam4.1294 · Cited by 43
Replication stress response in cancer stem cells as a target for chemotherapy
Manic, G., Sistigu, A., Corradi, F., Musella, M., Maria, R. D., & Vitale, I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.003 · Cited by 42
Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis
Guo, Y., Bao, Y., & Yang, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040890 · Cited by 41
Tian, X., Tao, F., Zhang, B., Dong, J., & Zhang, Z. (2018) · IUBMB Life · doi:10.1002/iub.1720 · Cited by 37
Liu, G., Ji, L., Ke, M., Ou, Z., Tang, N., & Li, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.114 · Cited by 35
Provvisiero, D. P., Negri, M., de Angelis, C., Gennaro, G. D., Patalano, R., Simeoli, C., Papa, F., Ferrigno, R., Auriemma, R. S., de Martino, M. C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48081-9 · Cited by 33
Narita, M., Shimura, E., Nagasawa, A., Aiuchi, T., Suda, Y., Hamada, Y., Ikegami, D., Iwasawa, C., Arakawa, K., Igarashi, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172115 · Cited by 32
Regulation of intestinal cancer stem cells
Ashley, N. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.016 · Cited by 28
MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells
Wang, L., Su, J., Zhao, Z., Hou, Y., Yin, X., Zheng, N., Zhou, X., Yan, J., Xia, J., & Wang, Z. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1367071 · Cited by 28
Stromal‐induced downregulation of miR‐1247 promotes prostate cancer malignancy
Taddei, M. L., Cavallini, L., Ramazzotti, M., Comito, G., Pietrovito, L., Morandi, A., Giannoni, E., Raugei, G., & Chiarugi, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27679 · Cited by 28
Yu, J., Zhang, W., Gao, F., Liu, Y.-X., Chen, Z., Cheng, L., Xie, S.-F., & Zheng, S. (2014) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60029-1 · Cited by 27
Self-citationHan, Q., Peng, C., Yang, H., Liang, H., & Lin, F. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29554 · Cited by 27
Wei, T., Zhu, W., Fang, S., Zeng, X., Huang, J., Yang, J., Zhang, J., & Guo, L. (2017) · PubMed · Cited by 27
Kong, W. W., He, L., Coppola, M., Guo, J., Esposito, N. N., Coppola, D., & Cheng, J. Q. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a110.101055 · Cited by 27
Okazaki, J., Tanahashi, T., Sato, Y., Miyoshi, J., Nakagawa, T., Kimura, T., Miyamoto, H., Fujino, Y., Nakamura, F., Takehara, M., et al. (2019) · Digestion · doi:10.1159/000503225 · Cited by 25
Identifying miRNA sponge modules using biclustering and regulatory scores
Zhang, J., Le, T. D., Liu, L., et al. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1467-5 · Cited by 22
Funamizu, N., Lacy, C., Kamada, M., Yanaga, K. K., & Manome, Y. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4676 · Cited by 22
Wang, S.-Y., Chen, C.-L., Hu, Y.-C., Chi, Y., Huang, Y., Su, C., Jeng, W., Liang, Y., & Wu, J. (2019) · Cancers · doi:10.3390/cancers11101549 · Cited by 15
Cited by
Targeting epigenetic regulators to overcome drug resistance in cancers
Wang, N., Ma, T., & Yu, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01341-7 · Cited by 311
Tumor cell plasticity in targeted therapy-induced resistance: Mechanisms and new strategies
Shi, Z.-D., Pang, K., Wu, Z.-X., Dong, Y., Hao, L., Qin, J.-X., Wang, W., Chen, Z.-S., & Han, C.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01383-x · Cited by 256
Metadata
- Authors
- Pan, G., Liu, Y., Shang, L., Zhou, F., & Yang, S.
- Venue
- Cancer Communications
- Published
- 2021-01-27
- Volume
- 41
- Issue
- 3
- Pages
- 199-217
- ISSN
- 1000-467X (ISSN-L)
- 2523-3548
- OpenAlex
- W3124226459
- Cited by
- 362
- References
- 156
- FWCI
- 20.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.